Correlation of ctDNA molecular response with secondary endpoints
Patients with mR attained longer PFS than patients with mPD (median PFS 5.03 months versus 2.6 months for patients with ctDNA mR and mPD, respectively) (Fig. We next explored the correlation of the degree of ctDNA reduction with radiographic RECIST response (Fig. 